Job (Principal Scientist in metabolic and inflammatory disease biology)

BE THE NEW

Principal Scientist in metabolic and inflammatory disease biology

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

Currently, we are looking for a new Principal Scientist for Department of Molecular Pharmacology. We are searching to expand our team, with a person possessing in-depth knowledge in the fields of metabolism, obesity and inflammation. In addition, our new colleague should have a passion for and experience with development of in vitro/ex vivo translational disease models. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us.

Department of Molecular Pharmacology comprise a team of 10 scientists and 7 technicians dedicated to advancing our research and development projects through the generation of in vitro, ex vivo and biomarker data. As a team, we use a range of biochemical and cellular assays to support the identification and optimization of our drug candidates. We use molecular biology methodologies for cell line establishment and protein characterization studies. We also support projects with biological understanding of the mechanism of action of our drug candidates. To build our future pipeline, we take part in the innovation process by identification, initiation and maturation of new projects.

Zealand Pharma is a small and flexible organization with many opportunities to impact projects across all stages of the pipeline as well as your development and the future project pipeline.

Responsibilities
As a Principal Scientist, you will work with colleagues from other departments in cross-company projects. As a representative for the department, you will provide understanding of disease mechanisms, cell biology and biochemical assays to the project teams. Internally in the department, you will participate in suggesting and developing the required in vitro and ex vivo assays and analyzing, discussing and presenting data.

In this role you will:

Work with the department scientists and technicians to deliver data, conclusions and recommendations to our research and development projects.
Identify and implement new assays, technologies, and methods in the lab, independently and with other members of the department.
Be one of the drivers in identification, maturation, and/or evaluation of new project ideas.
Represent the department on several research/development projects, providing input to the project concept, science, and plans, as well as overseeing these plans in the department.
On selected projects, take the role of project manager, leading the project team on a path to discover and develop new clinical candidates.

Candidate profile

We are looking for a passionate scientist and open-minded colleague, who has most or all of the below qualifications:

A PhD degree in cell biology within metabolism or inflammatory disease or a related field with 10+ years of experience with research and/or drug discovery
Hands-on experience with cell-based assays, primary cells and possibly biomarkers
Experience with close collaboration and supervision of lab technicians and students
Experience with analysis of large data sets is desirable, but not a requirement
Experience with Drug Discovery Project Management in pharma/biotech is a plus
A good balance between high level overview and an eye for details when needed
Positive attitude, drive and excellent communication skills
Proven scientific track record, showing the ability to work independently and in collaborative teams
A person with good interpersonal skills actively contributing to a good work environment

Bonding to innovate 

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise.

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.

Let’s bond and be bold 

We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities

To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/

Interested? Please apply as soon as possible and no later than November 25, 2024. The applications will be reviewed as they come in. You do not need to attach a motivational cover letter to your application, but please include a few sentences on your motivation and why you are applying in your resume or CV.

For further information, please contact Head of In vitro biology Gitte Lund Christensen GLChristensen@zealandpharma.com or Senior Director Jacob Fog JFog@zealandpharma.com

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.